Physician profile
Arvind B Soni
NPI 1255307914
$4,083.96
in general payments reported to CMS, 2019-2025
30 companies · $1,176 in 2025
The $1,176 reported for 2025 was more than what 85% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $69.96 · 2020: $44.75 · 2021: $171 · 2022: $353 · 2023: $1,225 · 2024: $1,044 · 2025: $1,176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,287 · Education: $158.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,286.73 |
| Education | $157.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $648.45 | 2021-2025 | Erleada, Akeega |
| Isoray, INC | $616.50 | 2023-2024 | Brachytherapy Source |
| Dendreon Pharmaceuticals LLC | $574.85 | 2023-2025 | Provenge |
| Bayer Healthcare Pharmaceuticals INC. | $401.51 | 2020-2025 | |
| Boston Scientific Corporation | $252.01 | 2021-2025 | Spaceoar Vue System - 10ml, Spaceoar System |
| Pfizer INC. | $219.58 | 2023-2024 | |
| Astellas Pharma US INC | $192.74 | 2021-2025 | Xtandi |
| Progenics Pharmaceuticals, INC. | $153.71 | 2023-2025 | Pylarify |
| Novartis Pharmaceuticals Corporation | $137.09 | 2023-2025 | |
| Bioprotect Medical, INC. | $128.88 | 2025 | Bioprotect Balloon Implant System |
| Gt Medical Technologies, INC | $120.92 | 2025 | Gammatile |
| Abbvie INC. | $101.18 | 2022-2025 | Lupron Depot |
| Myovant Sciences INC. | $59.63 | 2021-2022 | |
| Amgen INC. | $53.08 | 2021-2022 | |
| Blue Earth Diagnostics | $50.16 | 2025 | Posluma |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $48.25 | 2024 | |
| Sumitomo Pharma America, INC. | $43.01 | 2023-2024 | Orgovyx |
| Sun Pharmaceutical Industries INC. | $34.80 | 2022 | |
| Merck Sharp & Dohme LLC | $30.92 | 2020-2025 | Keytruda |
| Bard Peripheral Vascular, INC. | $29.54 | 2025 | Model 200 Theraseed Palladium-103 In Readylink |
| Foundation Medicine, INC. | $27.39 | 2023 | |
| Tolmar, INC. | $20.67 | 2025 | Eligard |
| Aurobindo Pharma USA, INC. | $20.16 | 2019 | |
| Telix Pharmaceuticals | $19.93 | 2023 | Illuccix |
| Daiichi Sankyo INC. | $19.01 | 2020 | |
| Rigel Pharmaceuticals, INC. | $18.81 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $18.46 | 2019 | |
| Sagent Pharmaceuticals | $16.32 | 2025 | Glydo |
| Palette Life Sciences, INC. | $13.87 | 2022 | |
| Clovis Oncology, INC. | $12.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arvind Soni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.